Two World Health Organization-affiliated bodies studied the same evidence on aspartame. On the same day, they published verdicts that sounded like they contradicted each other. They didn't, not technically. But the reason they didn't is more interesting than a simple disagreement would have been.
On July 14, 2023, the International Agency for Research on Cancer, WHO's cancer research arm, classified aspartame as Group 2B, "possibly carcinogenic to humans." The classification came out of IARC's 134th Monograph meeting, held in June 2023, and rested on three streams of evidence the agency itself described as limited: three human studies linking artificially sweetened beverage consumption to liver cancer, in which, IARC's summary notes, "bias or confounding could not be ruled out"; animal studies showing increased tumor incidence in mice and rats; and mechanistic evidence that aspartame can trigger oxidative stress in laboratory systems.
That same day, the Joint FAO/WHO Expert Committee on Food Additives, the body that actually sets how much of a food additive is safe to eat, reviewed the identical evidence and reaffirmed aspartame's Acceptable Daily Intake at 0 to 40 milligrams per kilogram of body weight, unchanged from its previous evaluation in 2016.
IARC and JECFA released their findings together, in a joint press release describing their work as "independent but complementary reviews." WHO spelled out what the unchanged limit means in practice: a 70-kilogram adult would need to drink more than 9 to 14 cans of diet soda a day, every day, to exceed it.
Hazard and intake questions compared
The split wasn't a disagreement about the facts. It was two different questions asked of the same evidence. IARC's classification system asks only whether a substance can, under any circumstance and at any dose, cause cancer. That is a hazard question, and it does not weigh how much exposure people actually get.
Group 2B, the category aspartame now sits in, also holds aloe vera whole-leaf extract and traditionally pickled Asian vegetables. JECFA asks a different question: at what level does real-world exposure become risky. Aspartame landing in "possibly carcinogenic" while its daily intake limit didn't move by a single milligram is what happens when two legitimate, differently scoped scientific questions get asked about the same chemical on the same day.
How we got here
Aspartame is not new, and neither is scrutiny of it. FDA first authorized it as a food additive in 1974, withdrew that approval for further review, and reinstated it in 1981 with an Acceptable Daily Intake of 50 mg/kg body weight, a figure FDA still cites today and one that sits above, not below, JECFA's current 40 mg/kg limit.
The European Food Safety Authority ran its own full re-evaluation in 2013, reviewing essentially every safety study on aspartame available at the time, and concluded it was safe at current levels of exposure, setting the same 0-40 mg/kg limit JECFA later reaffirmed in 2016 and again in 2023.
By the time IARC's classification landed in July 2023, FDA, EFSA, and JECFA had each already scrutinized aspartame's cancer risk and had not moved their intake limits.
The evidence IARC weighed
The three human studies IARC leaned on hardest were observational: they tracked people's reported consumption of artificially sweetened beverages as a proxy for aspartame intake specifically, and found a positive association with liver cancer. IARC's own summary names the limitation directly, that the studies could not rule out that people who drink more diet soda differ from people who don't in ways that also affect cancer risk.
That is the standard caveat attached to observational nutrition research, and it is why IARC rated the human evidence "limited" rather than "sufficient" — a distinction the agency's own classification system draws explicitly.
FDA did not quietly accept the classification. Its stated position is direct: "The FDA disagrees with IARC's conclusion that these studies support classifying aspartame as a possible carcinogen to humans." The agency maintains that aspartame remains authorized as a sweetening agent and flavor enhancer under 21 CFR 172.804, keeps its own ADI at 50 mg/kg body weight, and says its scientists "do not have safety concerns when aspartame is used under the approved conditions."
Where regulators differ
This is where the usual U.S.-versus-Europe pattern breaks down. The EU's food additive rulebook, Regulation 1333/2008, still authorizes aspartame as E951, and EFSA has not revised its 2013 conclusion since the 2023 IARC classification. FDA and EU regulators, who have split publicly on synthetic dyes, titanium dioxide, and a handful of preservatives, land in the same place here.
Both keep aspartame authorized, at intake limits neither has lowered. The real divergence in this story runs between IARC on one side and FDA, JECFA, and EFSA together on the other: hazard classification versus risk assessment, not a west-versus-Europe story.
California's Proposition 65 list of chemicals the state has determined cause cancer or reproductive harm does not include aspartame either, as of the most recent OEHHA update.
What the label shows
On a U.S. label, aspartame appears by name in the ingredient list. It shows up most often in diet sodas, sugar-free gum, some flavored yogurts and protein powders, and tabletop sweetener packets. Because aspartame breaks down in the body partly into phenylalanine, federal rule requires any product containing it to carry a specific bolded warning: "PHENYLKETONURICS: CONTAINS PHENYLALANINE," aimed at the small population with the genetic condition phenylketonuria, for whom phenylalanine buildup is a real and separate medical concern.
That warning line predates the 2023 cancer classification by more than four decades and has nothing to do with it. Worth knowing, so it doesn't get mistaken for a cancer warning it was never meant to be.
What PurityIQ shows
PurityIQ doesn't resolve the hazard-versus-risk question for you, and no one honestly can — IARC, JECFA, FDA, and EFSA are each doing their jobs correctly here, they're just answering different questions from the same data. What the app does is put the actual record in front of you at the shelf: which bodies have weighed in, what each one concluded, and when, cited to the source, no score attached.
You see what every agency actually said. You decide what it means for what's in the cart.
As of September 11, 2026: IARC's Group 2B classification and JECFA's 40 mg/kg ADI both stand unchanged since July 14, 2023. FDA disagrees with the classification and maintains its own 50 mg/kg ADI. EFSA has not revised its 2013 opinion. Aspartame is not on California's Proposition 65 list.
Sources
- IARC, Summary of Findings: Aspartame, IARC Monographs Volume 134 (July 14, 2023)
- JECFA, Summary of Findings: Aspartame (July 14, 2023)
- WHO, "Aspartame hazard and risk assessment results released" (July 14, 2023)
- IARC/JECFA, joint press release on aspartame (July 14, 2023)
- FDA, "Aspartame and Other Sweeteners in Food"
- 21 CFR 172.804, aspartame food additive listing (eCFR, current as of Sept. 2026)
- EFSA, "EFSA completes full risk assessment on aspartame and concludes it is safe at current levels of exposure" (Dec. 10, 2013)
- Regulation (EC) No 1333/2008, Annex II (E951 aspartame)
- California OEHHA, Proposition 65 chemicals list (current)